Advertisement

Topics

Thrombolytic Science, LLC Company Profile

15:00 EST 21st November 2018 | BioPortfolio

Thrombolytic Science, LLC (TSI) is a privately-held vascular health and biotechnology company leading development of a next-generation, life-saving therapy to transform traditional medical approaches for treating blood clots caused by ischemic stroke and heart attacks – interventions that have not changed in decades. The company’s vision is to bring clot-busting therapy directly to the patient quickly, especially following an ischemic stroke, rather than having a patient wait to get to a hospital. TSI's dual, sequential thrombolytic regimen was established based upon research at Tufts University School of Medicine and Harvard Medical School, where scientists designed HisproUK. For more information, follow TSI on Twitter @ThrombolyticSci and visit tsillc.net.


News Articles [441 Associated News Articles listed on BioPortfolio]

Delivery of thrombolytic treatment for stroke in Helsinki beats expectations

Neurologists around the world are aware that the delivery of thrombolytic treatment for stroke in Helsinki University Hospital, Finland, is freaking fast - but is it too fast?

Migraines Mimicking Stroke Still Pose Diagnostic Challenges

(MedPage Today) -- Migraine with aura responsible for 18% of improper thrombolytic treatments

Biogen Buys Option to TMS' Phase II Stroke Candidate

Biogen has acquired an exclusive option to TMS’ Phase II acute stroke candidate TMS-007 and backup compounds through a deal that could generate up to $357 million-plus for the Japanese biotech and i...

Thrombolytic Science to Present at the 15th Anglo Nordic Life Science Investor Conference

Cambridge, Mass., USA, May 24, 2018 / B3C newswire / -- Thrombolytic Science, LLC (TSI), a clinical stage vascular health company developing biotechnology products to treat thrombotic diseases such a...

Half-Dose Alteplase Is Associated with Escalation of Care in Pulmonary Embolism Patients

Half doses were associated with additional thrombolytic dosing or mechanical thrombectomy.

CSIR-IMTECH's thrombolytic protein acquired by Epygen

The Council of Scientific & Industrial Research's Institute of Microbial Technology in India and Epygen Biotech agreed to wor -More- 

Thrombolytic Science to Participate in 2018 BIO International Conference

Company to Share Clinical Development Plans and Corporate Strategy with Potential Partners Cambridge, Mass., USA, May 31, 2018 / B3C newswire / -- Thrombolytic Science, LLC (TSI), a clinical stage va...

Science and She: Dr. Barbara Mugwanya Zawedde

Science and She is an online campaign of the International Service for the Acquisition of Agri-biotech Applications (ISAAA) and its network of Biotechnology Information Centers which aims to empower w...

PubMed Articles [423 Associated PubMed Articles listed on BioPortfolio]

Pentraxin-3 in Thrombolytic Therapy for Acute Ischemic Stroke: No Relation with Curative Effect and Prognosis.

BACKGROUND Pentraxin-3 (PTX3) is considered a high quality inflammatory marker of the severity and prognosis of several diseases, however, the value of PTX3 in thrombolytic therapy for acute ischemic ...

A case of cerebral infarction during a hemodialysis procedure successfully treated with recombinant tissue plasminogen activator.

Thrombolytic therapy is an effective treatment for acute ischemic stroke and provides benefits and improvements that lead to better neurological outcomes. However, thrombolytic therapy with recombinan...

Anesthetic Management of a Patient With Ongoing Thrombolytic Therapy During Decompressive Craniectomy: A Case Report.

Decompressive craniectomy (DC) is a therapeutic alternative for reducing intracranial pressure after a middle cerebral artery stroke. If thrombolytic therapy is administered, craniectomy is usually po...

Tissue Plasminogen Activator-Porous Magnetic Microrods for Targeted Thrombolytic Therapy after Ischemic Stroke.

Tissue plasminogen activator (tPA) is the only FDA approved thrombolytic drug for acute ischemic stroke but concerns regarding its limitations remain. Here, we developed a new strategy by incorporatin...

The relationship of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in peripheral blood with ST-segment resolution and the clinical outcomes of STEMI patients receiving thrombolytic therapy.

One of the inflammatory factors affecting the prognosis of myocardial infarction is the high level of neutrophil count in blood. In this study, we investigated the relationship of neutrophil-to-lympho...

Clinical Trials [319 Associated Clinical Trials listed on BioPortfolio]

Myocardial Infarction Triage and Intervention Project (MITI)

To determine the practicality, benefit, and safety of paramedic administration of thrombolytic therapy for acute myocardial infarction. The feasibility of paramedics correctly identifying...

Improving STEM Outcomes for Young Children With Language Learning Disabilities

The sophisticated language of science can be a barrier to Science, Technology, Engineering, and Math (STEM) learning, especially for children who have specific language impairment (SLI). T...

Cost Effectiveness if Primary PCI Versus Thrombolytic Therapy in Acute STEMI in Assiut University Hospital

Cost effectiveness between PPCI and thrombolytic therapy in STEMI patients without contraindications

Senior PAMI: Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly

This is a prospective, randomized, multi-center, international trial comparing two reperfusion strategies in elderly (age >= 70 years) patients with acute myocardial infarction: primary p...

Rural CT Examination and Thrombolytic Treatment for Stroke

To counteract long term sequelae from stroke you need ultrarapid diagnosis and treatment, high quality multidiciplinary in-hospital care and optimal long term rehabilitation. In this study...

Companies [975 Associated Companies listed on BioPortfolio]

Thrombolytic Science, LLC

Thrombolytic Science, LLC (TSI) is a privately-held vascular health and biotechnology company leading development of a next-generation, life-saving therapy to transform traditio...

FirstScience.com

Welcome to FirstScience.com. We are a leading Internet Science site that offers visitors a chance to explore the world of science through great science content. FirstScience.com is a premier resource ...

AngioDynamics, Inc.

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons and other physicians for the minimally-invasive treatment of ...

Academy of Finland

The Academy of Finland provides funding for high-quality scientific research, serves as an expert in science and science policy, and strengthens the position of science and research.The Academy is com...

Science SPIN

Science SPIN is Ireland's first science magazine. But it's not just for scientists; it's for anyone with a fascination for finding out how and why.Find out how animals communicate ... why computers ar...

More Information about "Thrombolytic Science, LLC" on BioPortfolio

We have published hundreds of Thrombolytic Science, LLC news stories on BioPortfolio along with dozens of Thrombolytic Science, LLC Clinical Trials and PubMed Articles about Thrombolytic Science, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Thrombolytic Science, LLC Companies in our database. You can also find out about relevant Thrombolytic Science, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Stroke - Cerebrovascular Disease (CVA)
A stroke is a serious medical condition that occurs when the blood supply to part of the brain is cut off. Strokes are a medical emergency and prompt treatment is essential because the sooner a person receives treatment for a stroke, the less damage is ...


Corporate Database Quicklinks



Searches Linking to this Company Record